- Home
- BBAR vs ZLAB Comparison
BBAR vs ZLAB Comparison
Compare BBAR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBAR | ZLAB |
|---|---|---|
| Founded | 1886 | 2013 |
| Country | Argentina | China |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | BBAR | ZLAB |
|---|---|---|
| Price | $18.33 | $17.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $22.00 | ★ $57.22 |
| AVG Volume (30 Days) | 792.0K | ★ 1.0M |
| Earning Date | 11-25-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,535,146,865.00 | $441,629,000.00 |
| Revenue This Year | N/A | $30.20 |
| Revenue Next Year | $19.02 | $34.71 |
| P/E Ratio | $30.51 | ★ N/A |
| Revenue Growth | N/A | ★ 24.14 |
| 52 Week Low | $7.76 | $16.82 |
| 52 Week High | $25.01 | $44.34 |
Technical Indicators
Market Signals| Indicator | BBAR | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 69.78 | 31.02 |
| Support Level | $16.21 | $16.82 |
| Resistance Level | $17.37 | $18.67 |
| Average True Range (ATR) | 0.91 | 0.60 |
| MACD | 0.07 | 0.13 |
| Stochastic Oscillator | 79.08 | 33.24 |
Price Performance
Historical ComparisonAbout BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.